Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-08

Clinical Trial Update: Urinary Titin Biomarker in DMD [NA]

View source ↗

Summary

Clinical trial update regarding a urinary titin biomarker study in Duchenne muscular dystrophy and Becker muscular dystrophy, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Children's Hospital of Philadelphia | Conditions: Duchenne Muscular Dystrophy (DMD), Becker's Muscular Dystrophy (BMD) | NA | Status: RECRUITING